ALNY icon

Alnylam Pharmaceuticals

493 hedge funds and large institutions have $26.7B invested in Alnylam Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 118 funds opening new positions, 170 increasing their positions, 148 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

17.71% more ownership

Funds ownership: 93.86%111.57% (+18%)

15% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 148

11% more call options, than puts

Call options by funds: $298M | Put options by funds: $270M

Holders
493
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$298M
Puts
$270M
Net Calls
Net Calls Change

Top Buyers

1 +$3.26B
2 +$732M
3 +$140M
4
Holocene Advisors
Holocene Advisors
New York
+$129M
5
Invesco
Invesco
Georgia
+$114M
Name Holding Trade Value Shares
Change
Change in
Stake
201
$2.44M
202
$2.4M
203
$2.4M
204
$2.39M
205
$2.38M
206
$2.35M
207
$2.34M
208
$2.3M
209
$2.26M
210
$2.26M
211
$2.25M
212
$2.25M
213
$2.23M
214
$2.19M
215
$2.18M
216
$2.14M
217
$2.13M
218
$2.11M
219
$2.08M
220
$2.08M
221
$2.08M
222
$2.05M
223
$2.03M
224
$1.91M
225
$1.87M